News

Medical Dialogues53m
Gilead Sciences gets USFDA nod for new Biktarvy indication for people with HIV who are treatment experienced, restarting antiretroviral treatment
Gilead Sciences, Inc. has announced that it has received new approval from the U.S. Food and Drug Administration (FDA) for a ...
STAT12h
AIDS activists sue HHS to obtain Gilead settlement over patents for HIV prevention pills
An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent ...
Two Shots A Year: How A New HIV Drug Is Tackling Stigma And Saving Lives
With Black women and straight men increasingly at risk, Gilead’s Yeztugo may finally offer a discreet, stigma-free way to ...
Why Gilead Sciences Stock Just Popped
Biopharmaceuticals stock Gilead Sciences (NASDAQ: GILD) jumped 2.5% through 12:30 p.m. ET Friday after Needham & Co. upgraded ...
Bridging the Gap: Gilead’s Work to Help End the HIV Epidemic
Similarly, Gilead has provided nearly $35.8 million in total philanthropic support for Black women-led and/or Black ...
New Atlas6d
The first 100% effective HIV prevention drug is approved and going global
An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...
Pennsylvania to receive $1.2M from Gilead over kickback scheme to promote HIV drugs
Attorney General Dave Sunday announced that Pennsylvania will receive over $1 million as part of a $202 million multistate settlement with Gilead Sciences, Inc. over an illegal kickback scheme to ...
Gilead, Global Fund finalize plan to supply HIV prevention drug to poor countries
Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to supply a long-acting HIV prevention drug to low-income countries, despite the ...